1.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Temporarily closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: PTC299-ONC-007-NF2, NF080100, NCT00911248
|
|
2.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: PTC299-ONC-003-BRC, BC050203, NCT00508586
|
|
3.
|
Phase: Phase I Type: Treatment Status: Temporarily closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: PTC299-ONC-004-AST, NCT00704821
|
|
4.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Temporarily closed Age: 3 to 21 Sponsor: NCI, Other Protocol IDs: CDR0000680634, U01CA081457, PBTC-031, PTC299-ONC-010-PBT, NCT01158300
|